Pancreatic cancer differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 26: | Line 26: | ||
* Imaging: Non-contrast helical CT | * Imaging: Non-contrast helical CT | ||
* Biopsy findings | * Biopsy findings | ||
* Serum IgG4 levels for autoimmune pancreatitis | |||
* For pancreatic NETs: | * For pancreatic NETs: | ||
** Gastrin levels | ** Gastrin levels | ||
Line 41: | Line 42: | ||
** MRI | ** MRI | ||
** MRCP | ** MRCP | ||
** USG bile duct | |||
** ERCP | |||
* Biopsy findings | * Biopsy findings | ||
|- | |- | ||
Line 51: | Line 54: | ||
** MRI | ** MRI | ||
** ERCP | ** ERCP | ||
** Upper GI Endoscopy | |||
* Biopsy findings | * Biopsy findings | ||
|- | |- |
Revision as of 00:41, 15 November 2017
Pancreatic cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pancreatic cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Pancreatic cancer differential diagnosis |
Risk calculators and risk factors for Pancreatic cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Pancreatic cancer must be differentiated from choledocholithiasis, pancreatic pseudocyst, cystic neoplasm and carcinoma of the biliary tract
Differentiating Pancreatic Cancer from other Diseases
The following diseases have a similar presentation as pancreatic cancer:
ORIGIN | DISEASES | DIFFERENTIATION BASED ON INVESTIGATIONS |
---|---|---|
Pancreas |
|
|
Bile duct |
|
|
Duodenum |
|
|
Lymphovascular
tissue |
|
|
Metastasis |
|
|